 Nutra Pharma is announcing the first private label agreement in expansion of their line of over-the-counter pain relievers and anti-inflammatory drugsPlantation, Florida--Newsfile Corp. - June 4, 2021 - Nutra Pharma Corporation OTC Pink: NPHC, a biotechnology company marketing Nyloxin, Pet Pain-Away, Luxury Feet and Equine Pain-Away in the over-the-counter OTC pain management market and which is also developing treatments for Multiple Sclerosis MS, Human Immunodeficiency Virus HIV and Pain, announced today their plans for increasing sales of their over-the-counter pain relievers through private label agreemen 